BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35257717)

  • 1. MCPIP1 regulates focal adhesion kinase and Rho GTPase-dependent migration in clear cell renal cell carcinoma.
    Gorka J; Marona P; Kwapisz O; Rys J; Jura J; Miekus K
    Eur J Pharmacol; 2022 May; 922():174804. PubMed ID: 35257717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs.
    Gorka J; Marona P; Kwapisz O; Waligórska A; Pospiech E; Dobrucki JW; Rys J; Jura J; Miekus K
    Oncogene; 2021 Dec; 40(50):6720-6735. PubMed ID: 34657130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-inflammatory protein MCPIP1 inhibits the development of ccRCC by maintaining high levels of tumour suppressors.
    Gorka J; Marona P; Kwapisz O; Rys J; Jura J; Miekus K
    Eur J Pharmacol; 2020 Dec; 888():173591. PubMed ID: 32971087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCPIP1 contributes to clear cell renal cell carcinomas development.
    Ligeza J; Marona P; Gach N; Lipert B; Miekus K; Wilk W; Jaszczynski J; Stelmach A; Loboda A; Dulak J; Branicki W; Rys J; Jura J
    Angiogenesis; 2017 Aug; 20(3):325-340. PubMed ID: 28197812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCPIP1 Downregulation in Clear Cell Renal Cell Carcinoma Promotes Vascularization and Metastatic Progression.
    Marona P; Górka J; Mazurek Z; Wilk W; Rys J; Majka M; Jura J; Miekus K
    Cancer Res; 2017 Sep; 77(18):4905-4920. PubMed ID: 28716897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation.
    Marona P; Górka J; Kwapisz O; Jura J; Rys J; Hoffman RM; Miekus K
    Cell Death Dis; 2022 Sep; 13(9):814. PubMed ID: 36138026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EphrinA1 activates a Src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility.
    Parri M; Buricchi F; Giannoni E; Grimaldi G; Mello T; Raugei G; Ramponi G; Chiarugi P
    J Biol Chem; 2007 Jul; 282(27):19619-28. PubMed ID: 17449913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capn4 contributes to tumor invasion and metastasis in clear cell renal cell carcinoma cells via modulating talin-focal adhesion kinase signaling pathway.
    Zhuang Q; Luo W; Zhang M; Fan M; Lu H; Xu R; He X
    Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):465-472. PubMed ID: 29648579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extremely low frequency electromagnetic fields promote mesenchymal stem cell migration by increasing intracellular Ca
    Zhang Y; Yan J; Xu H; Yang Y; Li W; Wu H; Liu C
    Stem Cell Res Ther; 2018 May; 9(1):143. PubMed ID: 29784011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of BAP1 Results in Growth Inhibition and Enhances Mesenchymal-Epithelial Transition in Kidney Tumor Cells.
    Chen P; Wang H; Zhang W; Chen Y; Lv Y; Wu D; Guo M; Deng H
    Mol Cell Proteomics; 2019 Jul; 18(7):1320-1329. PubMed ID: 30992312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperosmotic stress induces rapid focal adhesion kinase phosphorylation at tyrosines 397 and 577. Role of Src family kinases and Rho family GTPases.
    Lunn JA; Rozengurt E
    J Biol Chem; 2004 Oct; 279(43):45266-78. PubMed ID: 15302877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dysadherin/FAK axis promotes individual cell migration in colon cancer.
    Lee CJ; Jang TY; Kim JH; Lim S; Lee S; Nam JS
    Int J Biol Sci; 2024; 20(7):2356-2369. PubMed ID: 38725858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma.
    Salama MF; Carroll B; Adada M; Pulkoski-Gross M; Hannun YA; Obeid LM
    FASEB J; 2015 Jul; 29(7):2803-13. PubMed ID: 25805832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic 8-hydroxydeoxyguanosine inhibited metastasis of pancreatic cancer through concerted inhibitions of ERM and Rho-GTPase.
    Park JM; Han YM; Jeong M; Chung MH; Kwon CI; Ko KH; Hahm KB
    Free Radic Biol Med; 2017 Sep; 110():151-161. PubMed ID: 28602912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.
    Cheng HL; Lin CW; Yang JS; Hsieh MJ; Yang SF; Lu KH
    Oncotarget; 2016 Mar; 7(9):9742-58. PubMed ID: 26848867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
    Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW
    Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
    Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM
    BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.
    Yao X; Qi L; Chen X; Du J; Zhang Z; Liu S
    Urol Oncol; 2014 Feb; 32(2):162-70. PubMed ID: 23570708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCPIP1 Exogenous Overexpression Inhibits Pathways Regulating MYCN Oncoprotein Stability in Neuroblastoma.
    Boratyn E; Nowak I; Durbas M; Horwacik I; Sawicka A; Rokita H
    J Cell Biochem; 2017 Jul; 118(7):1741-1755. PubMed ID: 27935099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.